Global Female Contraception Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Female Contraception market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Female Contraception Industry Forecast” looks at past sales and reviews total world Female Contraception sales in 2023, providing a comprehensive analysis by region and market sector of projected Female Contraception sales for 2024 through 2030. With Female Contraception sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Female Contraception industry.
This Insight Report provides a comprehensive analysis of the global Female Contraception landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Female Contraception portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Female Contraception market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Female Contraception and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Female Contraception.
United States market for Female Contraception is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Female Contraception is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Female Contraception is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Female Contraception players cover Amgen Inc., Ansell Ltd., Exeltis USA Inc., Medisafe Distribution Inc., Merck & Co. Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Female Contraception market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Female Contraception market?
What factors are driving Female Contraception market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Female Contraception market opportunities vary by end market size?
How does Female Contraception break out by Type, by Application?
The global Female Contraception market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Female Contraception Industry Forecast” looks at past sales and reviews total world Female Contraception sales in 2023, providing a comprehensive analysis by region and market sector of projected Female Contraception sales for 2024 through 2030. With Female Contraception sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Female Contraception industry.
This Insight Report provides a comprehensive analysis of the global Female Contraception landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Female Contraception portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Female Contraception market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Female Contraception and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Female Contraception.
United States market for Female Contraception is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Female Contraception is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Female Contraception is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Female Contraception players cover Amgen Inc., Ansell Ltd., Exeltis USA Inc., Medisafe Distribution Inc., Merck & Co. Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Female Contraception market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Birth Control Pills
- Contraceptive Injection
- Contraceptive Patch
- IUDs
- Female Condom
- Others
- 18-25 Years Old
- 26-35 Years Old
- 36-45 Years Old
- ?45 Years Old
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Amgen Inc.
- Ansell Ltd.
- Exeltis USA Inc.
- Medisafe Distribution Inc.
- Merck & Co. Inc.
- Mylan NV
- Pfizer Inc.
- Piramal Enterprises Ltd.
- Afaxys Pharma LLC
- Agile Therapeutics Inc.
- Bayer AG
- CooperSurgical Inc.
- Cupid Ltd.
- Johnson & Johnson
- Mayer Laboratories Inc.
- Teva Pharmaceutical Industries Ltd
- Actavis, Inc.
- Gedeon Richter
- Novo Nordisk A/S
- ZiZhu
- Baijingyu
- Huazhong
- Sine
- AbbVie
- Church & Dwight
- Reckitt
- TherapeuticsMD
What is the 10-year outlook for the global Female Contraception market?
What factors are driving Female Contraception market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Female Contraception market opportunities vary by end market size?
How does Female Contraception break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Female Contraception Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Female Contraception by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Female Contraception by Country/Region, 2019, 2023 & 2030
2.2 Female Contraception Segment by Type
2.2.1 Birth Control Pills
2.2.2 Contraceptive Injection
2.2.3 Contraceptive Patch
2.2.4 IUDs
2.2.5 Female Condom
2.2.6 Others
2.3 Female Contraception Sales by Type
2.3.1 Global Female Contraception Sales Market Share by Type (2019-2024)
2.3.2 Global Female Contraception Revenue and Market Share by Type (2019-2024)
2.3.3 Global Female Contraception Sale Price by Type (2019-2024)
2.4 Female Contraception Segment by Application
2.4.1 18-25 Years Old
2.4.2 26-35 Years Old
2.4.3 36-45 Years Old
2.4.4 ?45 Years Old
2.4.5 Others
2.5 Female Contraception Sales by Application
2.5.1 Global Female Contraception Sale Market Share by Application (2019-2024)
2.5.2 Global Female Contraception Revenue and Market Share by Application (2019-2024)
2.5.3 Global Female Contraception Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Female Contraception Breakdown Data by Company
3.1.1 Global Female Contraception Annual Sales by Company (2019-2024)
3.1.2 Global Female Contraception Sales Market Share by Company (2019-2024)
3.2 Global Female Contraception Annual Revenue by Company (2019-2024)
3.2.1 Global Female Contraception Revenue by Company (2019-2024)
3.2.2 Global Female Contraception Revenue Market Share by Company (2019-2024)
3.3 Global Female Contraception Sale Price by Company
3.4 Key Manufacturers Female Contraception Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Female Contraception Product Location Distribution
3.4.2 Players Female Contraception Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR FEMALE CONTRACEPTION BY GEOGRAPHIC REGION
4.1 World Historic Female Contraception Market Size by Geographic Region (2019-2024)
4.1.1 Global Female Contraception Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Female Contraception Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Female Contraception Market Size by Country/Region (2019-2024)
4.2.1 Global Female Contraception Annual Sales by Country/Region (2019-2024)
4.2.2 Global Female Contraception Annual Revenue by Country/Region (2019-2024)
4.3 Americas Female Contraception Sales Growth
4.4 APAC Female Contraception Sales Growth
4.5 Europe Female Contraception Sales Growth
4.6 Middle East & Africa Female Contraception Sales Growth
5 AMERICAS
5.1 Americas Female Contraception Sales by Country
5.1.1 Americas Female Contraception Sales by Country (2019-2024)
5.1.2 Americas Female Contraception Revenue by Country (2019-2024)
5.2 Americas Female Contraception Sales by Type (2019-2024)
5.3 Americas Female Contraception Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Female Contraception Sales by Region
6.1.1 APAC Female Contraception Sales by Region (2019-2024)
6.1.2 APAC Female Contraception Revenue by Region (2019-2024)
6.2 APAC Female Contraception Sales by Type (2019-2024)
6.3 APAC Female Contraception Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Female Contraception by Country
7.1.1 Europe Female Contraception Sales by Country (2019-2024)
7.1.2 Europe Female Contraception Revenue by Country (2019-2024)
7.2 Europe Female Contraception Sales by Type (2019-2024)
7.3 Europe Female Contraception Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Female Contraception by Country
8.1.1 Middle East & Africa Female Contraception Sales by Country (2019-2024)
8.1.2 Middle East & Africa Female Contraception Revenue by Country (2019-2024)
8.2 Middle East & Africa Female Contraception Sales by Type (2019-2024)
8.3 Middle East & Africa Female Contraception Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Female Contraception
10.3 Manufacturing Process Analysis of Female Contraception
10.4 Industry Chain Structure of Female Contraception
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Female Contraception Distributors
11.3 Female Contraception Customer
12 WORLD FORECAST REVIEW FOR FEMALE CONTRACEPTION BY GEOGRAPHIC REGION
12.1 Global Female Contraception Market Size Forecast by Region
12.1.1 Global Female Contraception Forecast by Region (2025-2030)
12.1.2 Global Female Contraception Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Female Contraception Forecast by Type (2025-2030)
12.7 Global Female Contraception Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Amgen Inc.
13.1.1 Amgen Inc. Company Information
13.1.2 Amgen Inc. Female Contraception Product Portfolios and Specifications
13.1.3 Amgen Inc. Female Contraception Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Amgen Inc. Main Business Overview
13.1.5 Amgen Inc. Latest Developments
13.2 Ansell Ltd.
13.2.1 Ansell Ltd. Company Information
13.2.2 Ansell Ltd. Female Contraception Product Portfolios and Specifications
13.2.3 Ansell Ltd. Female Contraception Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Ansell Ltd. Main Business Overview
13.2.5 Ansell Ltd. Latest Developments
13.3 Exeltis USA Inc.
13.3.1 Exeltis USA Inc. Company Information
13.3.2 Exeltis USA Inc. Female Contraception Product Portfolios and Specifications
13.3.3 Exeltis USA Inc. Female Contraception Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Exeltis USA Inc. Main Business Overview
13.3.5 Exeltis USA Inc. Latest Developments
13.4 Medisafe Distribution Inc.
13.4.1 Medisafe Distribution Inc. Company Information
13.4.2 Medisafe Distribution Inc. Female Contraception Product Portfolios and Specifications
13.4.3 Medisafe Distribution Inc. Female Contraception Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Medisafe Distribution Inc. Main Business Overview
13.4.5 Medisafe Distribution Inc. Latest Developments
13.5 Merck & Co. Inc.
13.5.1 Merck & Co. Inc. Company Information
13.5.2 Merck & Co. Inc. Female Contraception Product Portfolios and Specifications
13.5.3 Merck & Co. Inc. Female Contraception Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Merck & Co. Inc. Main Business Overview
13.5.5 Merck & Co. Inc. Latest Developments
13.6 Mylan NV
13.6.1 Mylan NV Company Information
13.6.2 Mylan NV Female Contraception Product Portfolios and Specifications
13.6.3 Mylan NV Female Contraception Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Mylan NV Main Business Overview
13.6.5 Mylan NV Latest Developments
13.7 Pfizer Inc.
13.7.1 Pfizer Inc. Company Information
13.7.2 Pfizer Inc. Female Contraception Product Portfolios and Specifications
13.7.3 Pfizer Inc. Female Contraception Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Pfizer Inc. Main Business Overview
13.7.5 Pfizer Inc. Latest Developments
13.8 Piramal Enterprises Ltd.
13.8.1 Piramal Enterprises Ltd. Company Information
13.8.2 Piramal Enterprises Ltd. Female Contraception Product Portfolios and Specifications
13.8.3 Piramal Enterprises Ltd. Female Contraception Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Piramal Enterprises Ltd. Main Business Overview
13.8.5 Piramal Enterprises Ltd. Latest Developments
13.9 Afaxys Pharma LLC
13.9.1 Afaxys Pharma LLC Company Information
13.9.2 Afaxys Pharma LLC Female Contraception Product Portfolios and Specifications
13.9.3 Afaxys Pharma LLC Female Contraception Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Afaxys Pharma LLC Main Business Overview
13.9.5 Afaxys Pharma LLC Latest Developments
13.10 Agile Therapeutics Inc.
13.10.1 Agile Therapeutics Inc. Company Information
13.10.2 Agile Therapeutics Inc. Female Contraception Product Portfolios and Specifications
13.10.3 Agile Therapeutics Inc. Female Contraception Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Agile Therapeutics Inc. Main Business Overview
13.10.5 Agile Therapeutics Inc. Latest Developments
13.11 Bayer AG
13.11.1 Bayer AG Company Information
13.11.2 Bayer AG Female Contraception Product Portfolios and Specifications
13.11.3 Bayer AG Female Contraception Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Bayer AG Main Business Overview
13.11.5 Bayer AG Latest Developments
13.12 CooperSurgical Inc.
13.12.1 CooperSurgical Inc. Company Information
13.12.2 CooperSurgical Inc. Female Contraception Product Portfolios and Specifications
13.12.3 CooperSurgical Inc. Female Contraception Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 CooperSurgical Inc. Main Business Overview
13.12.5 CooperSurgical Inc. Latest Developments
13.13 Cupid Ltd.
13.13.1 Cupid Ltd. Company Information
13.13.2 Cupid Ltd. Female Contraception Product Portfolios and Specifications
13.13.3 Cupid Ltd. Female Contraception Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Cupid Ltd. Main Business Overview
13.13.5 Cupid Ltd. Latest Developments
13.14 Johnson & Johnson
13.14.1 Johnson & Johnson Company Information
13.14.2 Johnson & Johnson Female Contraception Product Portfolios and Specifications
13.14.3 Johnson & Johnson Female Contraception Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Johnson & Johnson Main Business Overview
13.14.5 Johnson & Johnson Latest Developments
13.15 Mayer Laboratories Inc.
13.15.1 Mayer Laboratories Inc. Company Information
13.15.2 Mayer Laboratories Inc. Female Contraception Product Portfolios and Specifications
13.15.3 Mayer Laboratories Inc. Female Contraception Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Mayer Laboratories Inc. Main Business Overview
13.15.5 Mayer Laboratories Inc. Latest Developments
13.16 Teva Pharmaceutical Industries Ltd
13.16.1 Teva Pharmaceutical Industries Ltd Company Information
13.16.2 Teva Pharmaceutical Industries Ltd Female Contraception Product Portfolios and Specifications
13.16.3 Teva Pharmaceutical Industries Ltd Female Contraception Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 Teva Pharmaceutical Industries Ltd Main Business Overview
13.16.5 Teva Pharmaceutical Industries Ltd Latest Developments
13.17 Actavis, Inc.
13.17.1 Actavis, Inc. Company Information
13.17.2 Actavis, Inc. Female Contraception Product Portfolios and Specifications
13.17.3 Actavis, Inc. Female Contraception Sales, Revenue, Price and Gross Margin (2019-2024)
13.17.4 Actavis, Inc. Main Business Overview
13.17.5 Actavis, Inc. Latest Developments
13.18 Gedeon Richter
13.18.1 Gedeon Richter Company Information
13.18.2 Gedeon Richter Female Contraception Product Portfolios and Specifications
13.18.3 Gedeon Richter Female Contraception Sales, Revenue, Price and Gross Margin (2019-2024)
13.18.4 Gedeon Richter Main Business Overview
13.18.5 Gedeon Richter Latest Developments
13.19 Novo Nordisk A/S
13.19.1 Novo Nordisk A/S Company Information
13.19.2 Novo Nordisk A/S Female Contraception Product Portfolios and Specifications
13.19.3 Novo Nordisk A/S Female Contraception Sales, Revenue, Price and Gross Margin (2019-2024)
13.19.4 Novo Nordisk A/S Main Business Overview
13.19.5 Novo Nordisk A/S Latest Developments
13.20 ZiZhu
13.20.1 ZiZhu Company Information
13.20.2 ZiZhu Female Contraception Product Portfolios and Specifications
13.20.3 ZiZhu Female Contraception Sales, Revenue, Price and Gross Margin (2019-2024)
13.20.4 ZiZhu Main Business Overview
13.20.5 ZiZhu Latest Developments
13.21 Baijingyu
13.21.1 Baijingyu Company Information
13.21.2 Baijingyu Female Contraception Product Portfolios and Specifications
13.21.3 Baijingyu Female Contraception Sales, Revenue, Price and Gross Margin (2019-2024)
13.21.4 Baijingyu Main Business Overview
13.21.5 Baijingyu Latest Developments
13.22 Huazhong
13.22.1 Huazhong Company Information
13.22.2 Huazhong Female Contraception Product Portfolios and Specifications
13.22.3 Huazhong Female Contraception Sales, Revenue, Price and Gross Margin (2019-2024)
13.22.4 Huazhong Main Business Overview
13.22.5 Huazhong Latest Developments
13.23 Sine
13.23.1 Sine Company Information
13.23.2 Sine Female Contraception Product Portfolios and Specifications
13.23.3 Sine Female Contraception Sales, Revenue, Price and Gross Margin (2019-2024)
13.23.4 Sine Main Business Overview
13.23.5 Sine Latest Developments
13.24 AbbVie
13.24.1 AbbVie Company Information
13.24.2 AbbVie Female Contraception Product Portfolios and Specifications
13.24.3 AbbVie Female Contraception Sales, Revenue, Price and Gross Margin (2019-2024)
13.24.4 AbbVie Main Business Overview
13.24.5 AbbVie Latest Developments
13.25 Church & Dwight
13.25.1 Church & Dwight Company Information
13.25.2 Church & Dwight Female Contraception Product Portfolios and Specifications
13.25.3 Church & Dwight Female Contraception Sales, Revenue, Price and Gross Margin (2019-2024)
13.25.4 Church & Dwight Main Business Overview
13.25.5 Church & Dwight Latest Developments
13.26 Reckitt
13.26.1 Reckitt Company Information
13.26.2 Reckitt Female Contraception Product Portfolios and Specifications
13.26.3 Reckitt Female Contraception Sales, Revenue, Price and Gross Margin (2019-2024)
13.26.4 Reckitt Main Business Overview
13.26.5 Reckitt Latest Developments
13.27 TherapeuticsMD
13.27.1 TherapeuticsMD Company Information
13.27.2 TherapeuticsMD Female Contraception Product Portfolios and Specifications
13.27.3 TherapeuticsMD Female Contraception Sales, Revenue, Price and Gross Margin (2019-2024)
13.27.4 TherapeuticsMD Main Business Overview
13.27.5 TherapeuticsMD Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Female Contraception Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Female Contraception by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Female Contraception by Country/Region, 2019, 2023 & 2030
2.2 Female Contraception Segment by Type
2.2.1 Birth Control Pills
2.2.2 Contraceptive Injection
2.2.3 Contraceptive Patch
2.2.4 IUDs
2.2.5 Female Condom
2.2.6 Others
2.3 Female Contraception Sales by Type
2.3.1 Global Female Contraception Sales Market Share by Type (2019-2024)
2.3.2 Global Female Contraception Revenue and Market Share by Type (2019-2024)
2.3.3 Global Female Contraception Sale Price by Type (2019-2024)
2.4 Female Contraception Segment by Application
2.4.1 18-25 Years Old
2.4.2 26-35 Years Old
2.4.3 36-45 Years Old
2.4.4 ?45 Years Old
2.4.5 Others
2.5 Female Contraception Sales by Application
2.5.1 Global Female Contraception Sale Market Share by Application (2019-2024)
2.5.2 Global Female Contraception Revenue and Market Share by Application (2019-2024)
2.5.3 Global Female Contraception Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Female Contraception Breakdown Data by Company
3.1.1 Global Female Contraception Annual Sales by Company (2019-2024)
3.1.2 Global Female Contraception Sales Market Share by Company (2019-2024)
3.2 Global Female Contraception Annual Revenue by Company (2019-2024)
3.2.1 Global Female Contraception Revenue by Company (2019-2024)
3.2.2 Global Female Contraception Revenue Market Share by Company (2019-2024)
3.3 Global Female Contraception Sale Price by Company
3.4 Key Manufacturers Female Contraception Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Female Contraception Product Location Distribution
3.4.2 Players Female Contraception Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR FEMALE CONTRACEPTION BY GEOGRAPHIC REGION
4.1 World Historic Female Contraception Market Size by Geographic Region (2019-2024)
4.1.1 Global Female Contraception Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Female Contraception Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Female Contraception Market Size by Country/Region (2019-2024)
4.2.1 Global Female Contraception Annual Sales by Country/Region (2019-2024)
4.2.2 Global Female Contraception Annual Revenue by Country/Region (2019-2024)
4.3 Americas Female Contraception Sales Growth
4.4 APAC Female Contraception Sales Growth
4.5 Europe Female Contraception Sales Growth
4.6 Middle East & Africa Female Contraception Sales Growth
5 AMERICAS
5.1 Americas Female Contraception Sales by Country
5.1.1 Americas Female Contraception Sales by Country (2019-2024)
5.1.2 Americas Female Contraception Revenue by Country (2019-2024)
5.2 Americas Female Contraception Sales by Type (2019-2024)
5.3 Americas Female Contraception Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Female Contraception Sales by Region
6.1.1 APAC Female Contraception Sales by Region (2019-2024)
6.1.2 APAC Female Contraception Revenue by Region (2019-2024)
6.2 APAC Female Contraception Sales by Type (2019-2024)
6.3 APAC Female Contraception Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Female Contraception by Country
7.1.1 Europe Female Contraception Sales by Country (2019-2024)
7.1.2 Europe Female Contraception Revenue by Country (2019-2024)
7.2 Europe Female Contraception Sales by Type (2019-2024)
7.3 Europe Female Contraception Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Female Contraception by Country
8.1.1 Middle East & Africa Female Contraception Sales by Country (2019-2024)
8.1.2 Middle East & Africa Female Contraception Revenue by Country (2019-2024)
8.2 Middle East & Africa Female Contraception Sales by Type (2019-2024)
8.3 Middle East & Africa Female Contraception Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Female Contraception
10.3 Manufacturing Process Analysis of Female Contraception
10.4 Industry Chain Structure of Female Contraception
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Female Contraception Distributors
11.3 Female Contraception Customer
12 WORLD FORECAST REVIEW FOR FEMALE CONTRACEPTION BY GEOGRAPHIC REGION
12.1 Global Female Contraception Market Size Forecast by Region
12.1.1 Global Female Contraception Forecast by Region (2025-2030)
12.1.2 Global Female Contraception Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Female Contraception Forecast by Type (2025-2030)
12.7 Global Female Contraception Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Amgen Inc.
13.1.1 Amgen Inc. Company Information
13.1.2 Amgen Inc. Female Contraception Product Portfolios and Specifications
13.1.3 Amgen Inc. Female Contraception Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Amgen Inc. Main Business Overview
13.1.5 Amgen Inc. Latest Developments
13.2 Ansell Ltd.
13.2.1 Ansell Ltd. Company Information
13.2.2 Ansell Ltd. Female Contraception Product Portfolios and Specifications
13.2.3 Ansell Ltd. Female Contraception Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Ansell Ltd. Main Business Overview
13.2.5 Ansell Ltd. Latest Developments
13.3 Exeltis USA Inc.
13.3.1 Exeltis USA Inc. Company Information
13.3.2 Exeltis USA Inc. Female Contraception Product Portfolios and Specifications
13.3.3 Exeltis USA Inc. Female Contraception Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Exeltis USA Inc. Main Business Overview
13.3.5 Exeltis USA Inc. Latest Developments
13.4 Medisafe Distribution Inc.
13.4.1 Medisafe Distribution Inc. Company Information
13.4.2 Medisafe Distribution Inc. Female Contraception Product Portfolios and Specifications
13.4.3 Medisafe Distribution Inc. Female Contraception Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Medisafe Distribution Inc. Main Business Overview
13.4.5 Medisafe Distribution Inc. Latest Developments
13.5 Merck & Co. Inc.
13.5.1 Merck & Co. Inc. Company Information
13.5.2 Merck & Co. Inc. Female Contraception Product Portfolios and Specifications
13.5.3 Merck & Co. Inc. Female Contraception Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Merck & Co. Inc. Main Business Overview
13.5.5 Merck & Co. Inc. Latest Developments
13.6 Mylan NV
13.6.1 Mylan NV Company Information
13.6.2 Mylan NV Female Contraception Product Portfolios and Specifications
13.6.3 Mylan NV Female Contraception Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Mylan NV Main Business Overview
13.6.5 Mylan NV Latest Developments
13.7 Pfizer Inc.
13.7.1 Pfizer Inc. Company Information
13.7.2 Pfizer Inc. Female Contraception Product Portfolios and Specifications
13.7.3 Pfizer Inc. Female Contraception Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Pfizer Inc. Main Business Overview
13.7.5 Pfizer Inc. Latest Developments
13.8 Piramal Enterprises Ltd.
13.8.1 Piramal Enterprises Ltd. Company Information
13.8.2 Piramal Enterprises Ltd. Female Contraception Product Portfolios and Specifications
13.8.3 Piramal Enterprises Ltd. Female Contraception Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Piramal Enterprises Ltd. Main Business Overview
13.8.5 Piramal Enterprises Ltd. Latest Developments
13.9 Afaxys Pharma LLC
13.9.1 Afaxys Pharma LLC Company Information
13.9.2 Afaxys Pharma LLC Female Contraception Product Portfolios and Specifications
13.9.3 Afaxys Pharma LLC Female Contraception Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Afaxys Pharma LLC Main Business Overview
13.9.5 Afaxys Pharma LLC Latest Developments
13.10 Agile Therapeutics Inc.
13.10.1 Agile Therapeutics Inc. Company Information
13.10.2 Agile Therapeutics Inc. Female Contraception Product Portfolios and Specifications
13.10.3 Agile Therapeutics Inc. Female Contraception Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Agile Therapeutics Inc. Main Business Overview
13.10.5 Agile Therapeutics Inc. Latest Developments
13.11 Bayer AG
13.11.1 Bayer AG Company Information
13.11.2 Bayer AG Female Contraception Product Portfolios and Specifications
13.11.3 Bayer AG Female Contraception Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Bayer AG Main Business Overview
13.11.5 Bayer AG Latest Developments
13.12 CooperSurgical Inc.
13.12.1 CooperSurgical Inc. Company Information
13.12.2 CooperSurgical Inc. Female Contraception Product Portfolios and Specifications
13.12.3 CooperSurgical Inc. Female Contraception Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 CooperSurgical Inc. Main Business Overview
13.12.5 CooperSurgical Inc. Latest Developments
13.13 Cupid Ltd.
13.13.1 Cupid Ltd. Company Information
13.13.2 Cupid Ltd. Female Contraception Product Portfolios and Specifications
13.13.3 Cupid Ltd. Female Contraception Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Cupid Ltd. Main Business Overview
13.13.5 Cupid Ltd. Latest Developments
13.14 Johnson & Johnson
13.14.1 Johnson & Johnson Company Information
13.14.2 Johnson & Johnson Female Contraception Product Portfolios and Specifications
13.14.3 Johnson & Johnson Female Contraception Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Johnson & Johnson Main Business Overview
13.14.5 Johnson & Johnson Latest Developments
13.15 Mayer Laboratories Inc.
13.15.1 Mayer Laboratories Inc. Company Information
13.15.2 Mayer Laboratories Inc. Female Contraception Product Portfolios and Specifications
13.15.3 Mayer Laboratories Inc. Female Contraception Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Mayer Laboratories Inc. Main Business Overview
13.15.5 Mayer Laboratories Inc. Latest Developments
13.16 Teva Pharmaceutical Industries Ltd
13.16.1 Teva Pharmaceutical Industries Ltd Company Information
13.16.2 Teva Pharmaceutical Industries Ltd Female Contraception Product Portfolios and Specifications
13.16.3 Teva Pharmaceutical Industries Ltd Female Contraception Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 Teva Pharmaceutical Industries Ltd Main Business Overview
13.16.5 Teva Pharmaceutical Industries Ltd Latest Developments
13.17 Actavis, Inc.
13.17.1 Actavis, Inc. Company Information
13.17.2 Actavis, Inc. Female Contraception Product Portfolios and Specifications
13.17.3 Actavis, Inc. Female Contraception Sales, Revenue, Price and Gross Margin (2019-2024)
13.17.4 Actavis, Inc. Main Business Overview
13.17.5 Actavis, Inc. Latest Developments
13.18 Gedeon Richter
13.18.1 Gedeon Richter Company Information
13.18.2 Gedeon Richter Female Contraception Product Portfolios and Specifications
13.18.3 Gedeon Richter Female Contraception Sales, Revenue, Price and Gross Margin (2019-2024)
13.18.4 Gedeon Richter Main Business Overview
13.18.5 Gedeon Richter Latest Developments
13.19 Novo Nordisk A/S
13.19.1 Novo Nordisk A/S Company Information
13.19.2 Novo Nordisk A/S Female Contraception Product Portfolios and Specifications
13.19.3 Novo Nordisk A/S Female Contraception Sales, Revenue, Price and Gross Margin (2019-2024)
13.19.4 Novo Nordisk A/S Main Business Overview
13.19.5 Novo Nordisk A/S Latest Developments
13.20 ZiZhu
13.20.1 ZiZhu Company Information
13.20.2 ZiZhu Female Contraception Product Portfolios and Specifications
13.20.3 ZiZhu Female Contraception Sales, Revenue, Price and Gross Margin (2019-2024)
13.20.4 ZiZhu Main Business Overview
13.20.5 ZiZhu Latest Developments
13.21 Baijingyu
13.21.1 Baijingyu Company Information
13.21.2 Baijingyu Female Contraception Product Portfolios and Specifications
13.21.3 Baijingyu Female Contraception Sales, Revenue, Price and Gross Margin (2019-2024)
13.21.4 Baijingyu Main Business Overview
13.21.5 Baijingyu Latest Developments
13.22 Huazhong
13.22.1 Huazhong Company Information
13.22.2 Huazhong Female Contraception Product Portfolios and Specifications
13.22.3 Huazhong Female Contraception Sales, Revenue, Price and Gross Margin (2019-2024)
13.22.4 Huazhong Main Business Overview
13.22.5 Huazhong Latest Developments
13.23 Sine
13.23.1 Sine Company Information
13.23.2 Sine Female Contraception Product Portfolios and Specifications
13.23.3 Sine Female Contraception Sales, Revenue, Price and Gross Margin (2019-2024)
13.23.4 Sine Main Business Overview
13.23.5 Sine Latest Developments
13.24 AbbVie
13.24.1 AbbVie Company Information
13.24.2 AbbVie Female Contraception Product Portfolios and Specifications
13.24.3 AbbVie Female Contraception Sales, Revenue, Price and Gross Margin (2019-2024)
13.24.4 AbbVie Main Business Overview
13.24.5 AbbVie Latest Developments
13.25 Church & Dwight
13.25.1 Church & Dwight Company Information
13.25.2 Church & Dwight Female Contraception Product Portfolios and Specifications
13.25.3 Church & Dwight Female Contraception Sales, Revenue, Price and Gross Margin (2019-2024)
13.25.4 Church & Dwight Main Business Overview
13.25.5 Church & Dwight Latest Developments
13.26 Reckitt
13.26.1 Reckitt Company Information
13.26.2 Reckitt Female Contraception Product Portfolios and Specifications
13.26.3 Reckitt Female Contraception Sales, Revenue, Price and Gross Margin (2019-2024)
13.26.4 Reckitt Main Business Overview
13.26.5 Reckitt Latest Developments
13.27 TherapeuticsMD
13.27.1 TherapeuticsMD Company Information
13.27.2 TherapeuticsMD Female Contraception Product Portfolios and Specifications
13.27.3 TherapeuticsMD Female Contraception Sales, Revenue, Price and Gross Margin (2019-2024)
13.27.4 TherapeuticsMD Main Business Overview
13.27.5 TherapeuticsMD Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Female Contraception Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Female Contraception Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Birth Control Pills
Table 4. Major Players of Contraceptive Injection
Table 5. Major Players of Contraceptive Patch
Table 6. Major Players of IUDs
Table 7. Major Players of Female Condom
Table 8. Major Players of Others
Table 9. Global Female Contraception Sales by Type (2019-2024) & (K Units)
Table 10. Global Female Contraception Sales Market Share by Type (2019-2024)
Table 11. Global Female Contraception Revenue by Type (2019-2024) & ($ million)
Table 12. Global Female Contraception Revenue Market Share by Type (2019-2024)
Table 13. Global Female Contraception Sale Price by Type (2019-2024) & (US$/Unit)
Table 14. Global Female Contraception Sale by Application (2019-2024) & (K Units)
Table 15. Global Female Contraception Sale Market Share by Application (2019-2024)
Table 16. Global Female Contraception Revenue by Application (2019-2024) & ($ million)
Table 17. Global Female Contraception Revenue Market Share by Application (2019-2024)
Table 18. Global Female Contraception Sale Price by Application (2019-2024) & (US$/Unit)
Table 19. Global Female Contraception Sales by Company (2019-2024) & (K Units)
Table 20. Global Female Contraception Sales Market Share by Company (2019-2024)
Table 21. Global Female Contraception Revenue by Company (2019-2024) & ($ millions)
Table 22. Global Female Contraception Revenue Market Share by Company (2019-2024)
Table 23. Global Female Contraception Sale Price by Company (2019-2024) & (US$/Unit)
Table 24. Key Manufacturers Female Contraception Producing Area Distribution and Sales Area
Table 25. Players Female Contraception Products Offered
Table 26. Female Contraception Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 27. New Products and Potential Entrants
Table 28. Market M&A Activity & Strategy
Table 29. Global Female Contraception Sales by Geographic Region (2019-2024) & (K Units)
Table 30. Global Female Contraception Sales Market Share Geographic Region (2019-2024)
Table 31. Global Female Contraception Revenue by Geographic Region (2019-2024) & ($ millions)
Table 32. Global Female Contraception Revenue Market Share by Geographic Region (2019-2024)
Table 33. Global Female Contraception Sales by Country/Region (2019-2024) & (K Units)
Table 34. Global Female Contraception Sales Market Share by Country/Region (2019-2024)
Table 35. Global Female Contraception Revenue by Country/Region (2019-2024) & ($ millions)
Table 36. Global Female Contraception Revenue Market Share by Country/Region (2019-2024)
Table 37. Americas Female Contraception Sales by Country (2019-2024) & (K Units)
Table 38. Americas Female Contraception Sales Market Share by Country (2019-2024)
Table 39. Americas Female Contraception Revenue by Country (2019-2024) & ($ millions)
Table 40. Americas Female Contraception Sales by Type (2019-2024) & (K Units)
Table 41. Americas Female Contraception Sales by Application (2019-2024) & (K Units)
Table 42. APAC Female Contraception Sales by Region (2019-2024) & (K Units)
Table 43. APAC Female Contraception Sales Market Share by Region (2019-2024)
Table 44. APAC Female Contraception Revenue by Region (2019-2024) & ($ millions)
Table 45. APAC Female Contraception Sales by Type (2019-2024) & (K Units)
Table 46. APAC Female Contraception Sales by Application (2019-2024) & (K Units)
Table 47. Europe Female Contraception Sales by Country (2019-2024) & (K Units)
Table 48. Europe Female Contraception Revenue by Country (2019-2024) & ($ millions)
Table 49. Europe Female Contraception Sales by Type (2019-2024) & (K Units)
Table 50. Europe Female Contraception Sales by Application (2019-2024) & (K Units)
Table 51. Middle East & Africa Female Contraception Sales by Country (2019-2024) & (K Units)
Table 52. Middle East & Africa Female Contraception Revenue Market Share by Country (2019-2024)
Table 53. Middle East & Africa Female Contraception Sales by Type (2019-2024) & (K Units)
Table 54. Middle East & Africa Female Contraception Sales by Application (2019-2024) & (K Units)
Table 55. Key Market Drivers & Growth Opportunities of Female Contraception
Table 56. Key Market Challenges & Risks of Female Contraception
Table 57. Key Industry Trends of Female Contraception
Table 58. Female Contraception Raw Material
Table 59. Key Suppliers of Raw Materials
Table 60. Female Contraception Distributors List
Table 61. Female Contraception Customer List
Table 62. Global Female Contraception Sales Forecast by Region (2025-2030) & (K Units)
Table 63. Global Female Contraception Revenue Forecast by Region (2025-2030) & ($ millions)
Table 64. Americas Female Contraception Sales Forecast by Country (2025-2030) & (K Units)
Table 65. Americas Female Contraception Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 66. APAC Female Contraception Sales Forecast by Region (2025-2030) & (K Units)
Table 67. APAC Female Contraception Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 68. Europe Female Contraception Sales Forecast by Country (2025-2030) & (K Units)
Table 69. Europe Female Contraception Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. Middle East & Africa Female Contraception Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Middle East & Africa Female Contraception Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Global Female Contraception Sales Forecast by Type (2025-2030) & (K Units)
Table 73. Global Female Contraception Revenue Forecast by Type (2025-2030) & ($ millions)
Table 74. Global Female Contraception Sales Forecast by Application (2025-2030) & (K Units)
Table 75. Global Female Contraception Revenue Forecast by Application (2025-2030) & ($ millions)
Table 76. Amgen Inc. Basic Information, Female Contraception Manufacturing Base, Sales Area and Its Competitors
Table 77. Amgen Inc. Female Contraception Product Portfolios and Specifications
Table 78. Amgen Inc. Female Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 79. Amgen Inc. Main Business
Table 80. Amgen Inc. Latest Developments
Table 81. Ansell Ltd. Basic Information, Female Contraception Manufacturing Base, Sales Area and Its Competitors
Table 82. Ansell Ltd. Female Contraception Product Portfolios and Specifications
Table 83. Ansell Ltd. Female Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 84. Ansell Ltd. Main Business
Table 85. Ansell Ltd. Latest Developments
Table 86. Exeltis USA Inc. Basic Information, Female Contraception Manufacturing Base, Sales Area and Its Competitors
Table 87. Exeltis USA Inc. Female Contraception Product Portfolios and Specifications
Table 88. Exeltis USA Inc. Female Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 89. Exeltis USA Inc. Main Business
Table 90. Exeltis USA Inc. Latest Developments
Table 91. Medisafe Distribution Inc. Basic Information, Female Contraception Manufacturing Base, Sales Area and Its Competitors
Table 92. Medisafe Distribution Inc. Female Contraception Product Portfolios and Specifications
Table 93. Medisafe Distribution Inc. Female Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 94. Medisafe Distribution Inc. Main Business
Table 95. Medisafe Distribution Inc. Latest Developments
Table 96. Merck & Co. Inc. Basic Information, Female Contraception Manufacturing Base, Sales Area and Its Competitors
Table 97. Merck & Co. Inc. Female Contraception Product Portfolios and Specifications
Table 98. Merck & Co. Inc. Female Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 99. Merck & Co. Inc. Main Business
Table 100. Merck & Co. Inc. Latest Developments
Table 101. Mylan NV Basic Information, Female Contraception Manufacturing Base, Sales Area and Its Competitors
Table 102. Mylan NV Female Contraception Product Portfolios and Specifications
Table 103. Mylan NV Female Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 104. Mylan NV Main Business
Table 105. Mylan NV Latest Developments
Table 106. Pfizer Inc. Basic Information, Female Contraception Manufacturing Base, Sales Area and Its Competitors
Table 107. Pfizer Inc. Female Contraception Product Portfolios and Specifications
Table 108. Pfizer Inc. Female Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 109. Pfizer Inc. Main Business
Table 110. Pfizer Inc. Latest Developments
Table 111. Piramal Enterprises Ltd. Basic Information, Female Contraception Manufacturing Base, Sales Area and Its Competitors
Table 112. Piramal Enterprises Ltd. Female Contraception Product Portfolios and Specifications
Table 113. Piramal Enterprises Ltd. Female Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 114. Piramal Enterprises Ltd. Main Business
Table 115. Piramal Enterprises Ltd. Latest Developments
Table 116. Afaxys Pharma LLC Basic Information, Female Contraception Manufacturing Base, Sales Area and Its Competitors
Table 117. Afaxys Pharma LLC Female Contraception Product Portfolios and Specifications
Table 118. Afaxys Pharma LLC Female Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 119. Afaxys Pharma LLC Main Business
Table 120. Afaxys Pharma LLC Latest Developments
Table 121. Agile Therapeutics Inc. Basic Information, Female Contraception Manufacturing Base, Sales Area and Its Competitors
Table 122. Agile Therapeutics Inc. Female Contraception Product Portfolios and Specifications
Table 123. Agile Therapeutics Inc. Female Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 124. Agile Therapeutics Inc. Main Business
Table 125. Agile Therapeutics Inc. Latest Developments
Table 126. Bayer AG Basic Information, Female Contraception Manufacturing Base, Sales Area and Its Competitors
Table 127. Bayer AG Female Contraception Product Portfolios and Specifications
Table 128. Bayer AG Female Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 129. Bayer AG Main Business
Table 130. Bayer AG Latest Developments
Table 131. CooperSurgical Inc. Basic Information, Female Contraception Manufacturing Base, Sales Area and Its Competitors
Table 132. CooperSurgical Inc. Female Contraception Product Portfolios and Specifications
Table 133. CooperSurgical Inc. Female Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 134. CooperSurgical Inc. Main Business
Table 135. CooperSurgical Inc. Latest Developments
Table 136. Cupid Ltd. Basic Information, Female Contraception Manufacturing Base, Sales Area and Its Competitors
Table 137. Cupid Ltd. Female Contraception Product Portfolios and Specifications
Table 138. Cupid Ltd. Female Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 139. Cupid Ltd. Main Business
Table 140. Cupid Ltd. Latest Developments
Table 141. Johnson & Johnson Basic Information, Female Contraception Manufacturing Base, Sales Area and Its Competitors
Table 142. Johnson & Johnson Female Contraception Product Portfolios and Specifications
Table 143. Johnson & Johnson Female Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 144. Johnson & Johnson Main Business
Table 145. Johnson & Johnson Latest Developments
Table 146. Mayer Laboratories Inc. Basic Information, Female Contraception Manufacturing Base, Sales Area and Its Competitors
Table 147. Mayer Laboratories Inc. Female Contraception Product Portfolios and Specifications
Table 148. Mayer Laboratories Inc. Female Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 149. Mayer Laboratories Inc. Main Business
Table 150. Mayer Laboratories Inc. Latest Developments
Table 151. Teva Pharmaceutical Industries Ltd Basic Information, Female Contraception Manufacturing Base, Sales Area and Its Competitors
Table 152. Teva Pharmaceutical Industries Ltd Female Contraception Product Portfolios and Specifications
Table 153. Teva Pharmaceutical Industries Ltd Female Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 154. Teva Pharmaceutical Industries Ltd Main Business
Table 155. Teva Pharmaceutical Industries Ltd Latest Developments
Table 156. Actavis, Inc. Basic Information, Female Contraception Manufacturing Base, Sales Area and Its Competitors
Table 157. Actavis, Inc. Female Contraception Product Portfolios and Specifications
Table 158. Actavis, Inc. Female Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 159. Actavis, Inc. Main Business
Table 160. Actavis, Inc. Latest Developments
Table 161. Gedeon Richter Basic Information, Female Contraception Manufacturing Base, Sales Area and Its Competitors
Table 162. Gedeon Richter Female Contraception Product Portfolios and Specifications
Table 163. Gedeon Richter Female Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 164. Gedeon Richter Main Business
Table 165. Gedeon Richter Latest Developments
Table 166. Novo Nordisk A/S Basic Information, Female Contraception Manufacturing Base, Sales Area and Its Competitors
Table 167. Novo Nordisk A/S Female Contraception Product Portfolios and Specifications
Table 168. Novo Nordisk A/S Female Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 169. Novo Nordisk A/S Main Business
Table 170. Novo Nordisk A/S Latest Developments
Table 171. ZiZhu Basic Information, Female Contraception Manufacturing Base, Sales Area and Its Competitors
Table 172. ZiZhu Female Contraception Product Portfolios and Specifications
Table 173. ZiZhu Female Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 174. ZiZhu Main Business
Table 175. ZiZhu Latest Developments
Table 176. Baijingyu Basic Information, Female Contraception Manufacturing Base, Sales Area and Its Competitors
Table 177. Baijingyu Female Contraception Product Portfolios and Specifications
Table 178. Baijingyu Female Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 179. Baijingyu Main Business
Table 180. Baijingyu Latest Developments
Table 181. Huazhong Basic Information, Female Contraception Manufacturing Base, Sales Area and Its Competitors
Table 182. Huazhong Female Contraception Product Portfolios and Specifications
Table 183. Huazhong Female Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 184. Huazhong Main Business
Table 185. Huazhong Latest Developments
Table 186. Sine Basic Information, Female Contraception Manufacturing Base, Sales Area and Its Competitors
Table 187. Sine Female Contraception Product Portfolios and Specifications
Table 188. Sine Female Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 189. Sine Main Business
Table 190. Sine Latest Developments
Table 191. AbbVie Basic Information, Female Contraception Manufacturing Base, Sales Area and Its Competitors
Table 192. AbbVie Female Contraception Product Portfolios and Specifications
Table 193. AbbVie Female Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 194. AbbVie Main Business
Table 195. AbbVie Latest Developments
Table 196. Church & Dwight Basic Information, Female Contraception Manufacturing Base, Sales Area and Its Competitors
Table 197. Church & Dwight Female Contraception Product Portfolios and Specifications
Table 198. Church & Dwight Female Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 199. Church & Dwight Main Business
Table 200. Church & Dwight Latest Developments
Table 201. Reckitt Basic Information, Female Contraception Manufacturing Base, Sales Area and Its Competitors
Table 202. Reckitt Female Contraception Product Portfolios and Specifications
Table 203. Reckitt Female Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 204. Reckitt Main Business
Table 205. Reckitt Latest Developments
Table 206. TherapeuticsMD Basic Information, Female Contraception Manufacturing Base, Sales Area and Its Competitors
Table 207. TherapeuticsMD Female Contraception Product Portfolios and Specifications
Table 208. TherapeuticsMD Female Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 209. TherapeuticsMD Main Business
Table 210. TherapeuticsMD Latest Developments
Table 1. Female Contraception Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Female Contraception Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Birth Control Pills
Table 4. Major Players of Contraceptive Injection
Table 5. Major Players of Contraceptive Patch
Table 6. Major Players of IUDs
Table 7. Major Players of Female Condom
Table 8. Major Players of Others
Table 9. Global Female Contraception Sales by Type (2019-2024) & (K Units)
Table 10. Global Female Contraception Sales Market Share by Type (2019-2024)
Table 11. Global Female Contraception Revenue by Type (2019-2024) & ($ million)
Table 12. Global Female Contraception Revenue Market Share by Type (2019-2024)
Table 13. Global Female Contraception Sale Price by Type (2019-2024) & (US$/Unit)
Table 14. Global Female Contraception Sale by Application (2019-2024) & (K Units)
Table 15. Global Female Contraception Sale Market Share by Application (2019-2024)
Table 16. Global Female Contraception Revenue by Application (2019-2024) & ($ million)
Table 17. Global Female Contraception Revenue Market Share by Application (2019-2024)
Table 18. Global Female Contraception Sale Price by Application (2019-2024) & (US$/Unit)
Table 19. Global Female Contraception Sales by Company (2019-2024) & (K Units)
Table 20. Global Female Contraception Sales Market Share by Company (2019-2024)
Table 21. Global Female Contraception Revenue by Company (2019-2024) & ($ millions)
Table 22. Global Female Contraception Revenue Market Share by Company (2019-2024)
Table 23. Global Female Contraception Sale Price by Company (2019-2024) & (US$/Unit)
Table 24. Key Manufacturers Female Contraception Producing Area Distribution and Sales Area
Table 25. Players Female Contraception Products Offered
Table 26. Female Contraception Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 27. New Products and Potential Entrants
Table 28. Market M&A Activity & Strategy
Table 29. Global Female Contraception Sales by Geographic Region (2019-2024) & (K Units)
Table 30. Global Female Contraception Sales Market Share Geographic Region (2019-2024)
Table 31. Global Female Contraception Revenue by Geographic Region (2019-2024) & ($ millions)
Table 32. Global Female Contraception Revenue Market Share by Geographic Region (2019-2024)
Table 33. Global Female Contraception Sales by Country/Region (2019-2024) & (K Units)
Table 34. Global Female Contraception Sales Market Share by Country/Region (2019-2024)
Table 35. Global Female Contraception Revenue by Country/Region (2019-2024) & ($ millions)
Table 36. Global Female Contraception Revenue Market Share by Country/Region (2019-2024)
Table 37. Americas Female Contraception Sales by Country (2019-2024) & (K Units)
Table 38. Americas Female Contraception Sales Market Share by Country (2019-2024)
Table 39. Americas Female Contraception Revenue by Country (2019-2024) & ($ millions)
Table 40. Americas Female Contraception Sales by Type (2019-2024) & (K Units)
Table 41. Americas Female Contraception Sales by Application (2019-2024) & (K Units)
Table 42. APAC Female Contraception Sales by Region (2019-2024) & (K Units)
Table 43. APAC Female Contraception Sales Market Share by Region (2019-2024)
Table 44. APAC Female Contraception Revenue by Region (2019-2024) & ($ millions)
Table 45. APAC Female Contraception Sales by Type (2019-2024) & (K Units)
Table 46. APAC Female Contraception Sales by Application (2019-2024) & (K Units)
Table 47. Europe Female Contraception Sales by Country (2019-2024) & (K Units)
Table 48. Europe Female Contraception Revenue by Country (2019-2024) & ($ millions)
Table 49. Europe Female Contraception Sales by Type (2019-2024) & (K Units)
Table 50. Europe Female Contraception Sales by Application (2019-2024) & (K Units)
Table 51. Middle East & Africa Female Contraception Sales by Country (2019-2024) & (K Units)
Table 52. Middle East & Africa Female Contraception Revenue Market Share by Country (2019-2024)
Table 53. Middle East & Africa Female Contraception Sales by Type (2019-2024) & (K Units)
Table 54. Middle East & Africa Female Contraception Sales by Application (2019-2024) & (K Units)
Table 55. Key Market Drivers & Growth Opportunities of Female Contraception
Table 56. Key Market Challenges & Risks of Female Contraception
Table 57. Key Industry Trends of Female Contraception
Table 58. Female Contraception Raw Material
Table 59. Key Suppliers of Raw Materials
Table 60. Female Contraception Distributors List
Table 61. Female Contraception Customer List
Table 62. Global Female Contraception Sales Forecast by Region (2025-2030) & (K Units)
Table 63. Global Female Contraception Revenue Forecast by Region (2025-2030) & ($ millions)
Table 64. Americas Female Contraception Sales Forecast by Country (2025-2030) & (K Units)
Table 65. Americas Female Contraception Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 66. APAC Female Contraception Sales Forecast by Region (2025-2030) & (K Units)
Table 67. APAC Female Contraception Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 68. Europe Female Contraception Sales Forecast by Country (2025-2030) & (K Units)
Table 69. Europe Female Contraception Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. Middle East & Africa Female Contraception Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Middle East & Africa Female Contraception Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Global Female Contraception Sales Forecast by Type (2025-2030) & (K Units)
Table 73. Global Female Contraception Revenue Forecast by Type (2025-2030) & ($ millions)
Table 74. Global Female Contraception Sales Forecast by Application (2025-2030) & (K Units)
Table 75. Global Female Contraception Revenue Forecast by Application (2025-2030) & ($ millions)
Table 76. Amgen Inc. Basic Information, Female Contraception Manufacturing Base, Sales Area and Its Competitors
Table 77. Amgen Inc. Female Contraception Product Portfolios and Specifications
Table 78. Amgen Inc. Female Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 79. Amgen Inc. Main Business
Table 80. Amgen Inc. Latest Developments
Table 81. Ansell Ltd. Basic Information, Female Contraception Manufacturing Base, Sales Area and Its Competitors
Table 82. Ansell Ltd. Female Contraception Product Portfolios and Specifications
Table 83. Ansell Ltd. Female Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 84. Ansell Ltd. Main Business
Table 85. Ansell Ltd. Latest Developments
Table 86. Exeltis USA Inc. Basic Information, Female Contraception Manufacturing Base, Sales Area and Its Competitors
Table 87. Exeltis USA Inc. Female Contraception Product Portfolios and Specifications
Table 88. Exeltis USA Inc. Female Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 89. Exeltis USA Inc. Main Business
Table 90. Exeltis USA Inc. Latest Developments
Table 91. Medisafe Distribution Inc. Basic Information, Female Contraception Manufacturing Base, Sales Area and Its Competitors
Table 92. Medisafe Distribution Inc. Female Contraception Product Portfolios and Specifications
Table 93. Medisafe Distribution Inc. Female Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 94. Medisafe Distribution Inc. Main Business
Table 95. Medisafe Distribution Inc. Latest Developments
Table 96. Merck & Co. Inc. Basic Information, Female Contraception Manufacturing Base, Sales Area and Its Competitors
Table 97. Merck & Co. Inc. Female Contraception Product Portfolios and Specifications
Table 98. Merck & Co. Inc. Female Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 99. Merck & Co. Inc. Main Business
Table 100. Merck & Co. Inc. Latest Developments
Table 101. Mylan NV Basic Information, Female Contraception Manufacturing Base, Sales Area and Its Competitors
Table 102. Mylan NV Female Contraception Product Portfolios and Specifications
Table 103. Mylan NV Female Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 104. Mylan NV Main Business
Table 105. Mylan NV Latest Developments
Table 106. Pfizer Inc. Basic Information, Female Contraception Manufacturing Base, Sales Area and Its Competitors
Table 107. Pfizer Inc. Female Contraception Product Portfolios and Specifications
Table 108. Pfizer Inc. Female Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 109. Pfizer Inc. Main Business
Table 110. Pfizer Inc. Latest Developments
Table 111. Piramal Enterprises Ltd. Basic Information, Female Contraception Manufacturing Base, Sales Area and Its Competitors
Table 112. Piramal Enterprises Ltd. Female Contraception Product Portfolios and Specifications
Table 113. Piramal Enterprises Ltd. Female Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 114. Piramal Enterprises Ltd. Main Business
Table 115. Piramal Enterprises Ltd. Latest Developments
Table 116. Afaxys Pharma LLC Basic Information, Female Contraception Manufacturing Base, Sales Area and Its Competitors
Table 117. Afaxys Pharma LLC Female Contraception Product Portfolios and Specifications
Table 118. Afaxys Pharma LLC Female Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 119. Afaxys Pharma LLC Main Business
Table 120. Afaxys Pharma LLC Latest Developments
Table 121. Agile Therapeutics Inc. Basic Information, Female Contraception Manufacturing Base, Sales Area and Its Competitors
Table 122. Agile Therapeutics Inc. Female Contraception Product Portfolios and Specifications
Table 123. Agile Therapeutics Inc. Female Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 124. Agile Therapeutics Inc. Main Business
Table 125. Agile Therapeutics Inc. Latest Developments
Table 126. Bayer AG Basic Information, Female Contraception Manufacturing Base, Sales Area and Its Competitors
Table 127. Bayer AG Female Contraception Product Portfolios and Specifications
Table 128. Bayer AG Female Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 129. Bayer AG Main Business
Table 130. Bayer AG Latest Developments
Table 131. CooperSurgical Inc. Basic Information, Female Contraception Manufacturing Base, Sales Area and Its Competitors
Table 132. CooperSurgical Inc. Female Contraception Product Portfolios and Specifications
Table 133. CooperSurgical Inc. Female Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 134. CooperSurgical Inc. Main Business
Table 135. CooperSurgical Inc. Latest Developments
Table 136. Cupid Ltd. Basic Information, Female Contraception Manufacturing Base, Sales Area and Its Competitors
Table 137. Cupid Ltd. Female Contraception Product Portfolios and Specifications
Table 138. Cupid Ltd. Female Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 139. Cupid Ltd. Main Business
Table 140. Cupid Ltd. Latest Developments
Table 141. Johnson & Johnson Basic Information, Female Contraception Manufacturing Base, Sales Area and Its Competitors
Table 142. Johnson & Johnson Female Contraception Product Portfolios and Specifications
Table 143. Johnson & Johnson Female Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 144. Johnson & Johnson Main Business
Table 145. Johnson & Johnson Latest Developments
Table 146. Mayer Laboratories Inc. Basic Information, Female Contraception Manufacturing Base, Sales Area and Its Competitors
Table 147. Mayer Laboratories Inc. Female Contraception Product Portfolios and Specifications
Table 148. Mayer Laboratories Inc. Female Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 149. Mayer Laboratories Inc. Main Business
Table 150. Mayer Laboratories Inc. Latest Developments
Table 151. Teva Pharmaceutical Industries Ltd Basic Information, Female Contraception Manufacturing Base, Sales Area and Its Competitors
Table 152. Teva Pharmaceutical Industries Ltd Female Contraception Product Portfolios and Specifications
Table 153. Teva Pharmaceutical Industries Ltd Female Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 154. Teva Pharmaceutical Industries Ltd Main Business
Table 155. Teva Pharmaceutical Industries Ltd Latest Developments
Table 156. Actavis, Inc. Basic Information, Female Contraception Manufacturing Base, Sales Area and Its Competitors
Table 157. Actavis, Inc. Female Contraception Product Portfolios and Specifications
Table 158. Actavis, Inc. Female Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 159. Actavis, Inc. Main Business
Table 160. Actavis, Inc. Latest Developments
Table 161. Gedeon Richter Basic Information, Female Contraception Manufacturing Base, Sales Area and Its Competitors
Table 162. Gedeon Richter Female Contraception Product Portfolios and Specifications
Table 163. Gedeon Richter Female Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 164. Gedeon Richter Main Business
Table 165. Gedeon Richter Latest Developments
Table 166. Novo Nordisk A/S Basic Information, Female Contraception Manufacturing Base, Sales Area and Its Competitors
Table 167. Novo Nordisk A/S Female Contraception Product Portfolios and Specifications
Table 168. Novo Nordisk A/S Female Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 169. Novo Nordisk A/S Main Business
Table 170. Novo Nordisk A/S Latest Developments
Table 171. ZiZhu Basic Information, Female Contraception Manufacturing Base, Sales Area and Its Competitors
Table 172. ZiZhu Female Contraception Product Portfolios and Specifications
Table 173. ZiZhu Female Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 174. ZiZhu Main Business
Table 175. ZiZhu Latest Developments
Table 176. Baijingyu Basic Information, Female Contraception Manufacturing Base, Sales Area and Its Competitors
Table 177. Baijingyu Female Contraception Product Portfolios and Specifications
Table 178. Baijingyu Female Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 179. Baijingyu Main Business
Table 180. Baijingyu Latest Developments
Table 181. Huazhong Basic Information, Female Contraception Manufacturing Base, Sales Area and Its Competitors
Table 182. Huazhong Female Contraception Product Portfolios and Specifications
Table 183. Huazhong Female Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 184. Huazhong Main Business
Table 185. Huazhong Latest Developments
Table 186. Sine Basic Information, Female Contraception Manufacturing Base, Sales Area and Its Competitors
Table 187. Sine Female Contraception Product Portfolios and Specifications
Table 188. Sine Female Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 189. Sine Main Business
Table 190. Sine Latest Developments
Table 191. AbbVie Basic Information, Female Contraception Manufacturing Base, Sales Area and Its Competitors
Table 192. AbbVie Female Contraception Product Portfolios and Specifications
Table 193. AbbVie Female Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 194. AbbVie Main Business
Table 195. AbbVie Latest Developments
Table 196. Church & Dwight Basic Information, Female Contraception Manufacturing Base, Sales Area and Its Competitors
Table 197. Church & Dwight Female Contraception Product Portfolios and Specifications
Table 198. Church & Dwight Female Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 199. Church & Dwight Main Business
Table 200. Church & Dwight Latest Developments
Table 201. Reckitt Basic Information, Female Contraception Manufacturing Base, Sales Area and Its Competitors
Table 202. Reckitt Female Contraception Product Portfolios and Specifications
Table 203. Reckitt Female Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 204. Reckitt Main Business
Table 205. Reckitt Latest Developments
Table 206. TherapeuticsMD Basic Information, Female Contraception Manufacturing Base, Sales Area and Its Competitors
Table 207. TherapeuticsMD Female Contraception Product Portfolios and Specifications
Table 208. TherapeuticsMD Female Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 209. TherapeuticsMD Main Business
Table 210. TherapeuticsMD Latest Developments
LIST OF FIGURES
Figure 1. Picture of Female Contraception
Figure 2. Female Contraception Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Female Contraception Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Female Contraception Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Female Contraception Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Female Contraception Sales Market Share by Country/Region (2023)
Figure 10. Female Contraception Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Birth Control Pills
Figure 12. Product Picture of Contraceptive Injection
Figure 13. Product Picture of Contraceptive Patch
Figure 14. Product Picture of IUDs
Figure 15. Product Picture of Female Condom
Figure 16. Product Picture of Others
Figure 17. Global Female Contraception Sales Market Share by Type in 2023
Figure 18. Global Female Contraception Revenue Market Share by Type (2019-2024)
Figure 19. Female Contraception Consumed in 18-25 Years Old
Figure 20. Global Female Contraception Market: 18-25 Years Old (2019-2024) & (K Units)
Figure 21. Female Contraception Consumed in 26-35 Years Old
Figure 22. Global Female Contraception Market: 26-35 Years Old (2019-2024) & (K Units)
Figure 23. Female Contraception Consumed in 36-45 Years Old
Figure 24. Global Female Contraception Market: 36-45 Years Old (2019-2024) & (K Units)
Figure 25. Female Contraception Consumed in ?45 Years Old
Figure 26. Global Female Contraception Market: ?45 Years Old (2019-2024) & (K Units)
Figure 27. Female Contraception Consumed in Others
Figure 28. Global Female Contraception Market: Others (2019-2024) & (K Units)
Figure 29. Global Female Contraception Sale Market Share by Application (2023)
Figure 30. Global Female Contraception Revenue Market Share by Application in 2023
Figure 31. Female Contraception Sales by Company in 2023 (K Units)
Figure 32. Global Female Contraception Sales Market Share by Company in 2023
Figure 33. Female Contraception Revenue by Company in 2023 ($ millions)
Figure 34. Global Female Contraception Revenue Market Share by Company in 2023
Figure 35. Global Female Contraception Sales Market Share by Geographic Region (2019-2024)
Figure 36. Global Female Contraception Revenue Market Share by Geographic Region in 2023
Figure 37. Americas Female Contraception Sales 2019-2024 (K Units)
Figure 38. Americas Female Contraception Revenue 2019-2024 ($ millions)
Figure 39. APAC Female Contraception Sales 2019-2024 (K Units)
Figure 40. APAC Female Contraception Revenue 2019-2024 ($ millions)
Figure 41. Europe Female Contraception Sales 2019-2024 (K Units)
Figure 42. Europe Female Contraception Revenue 2019-2024 ($ millions)
Figure 43. Middle East & Africa Female Contraception Sales 2019-2024 (K Units)
Figure 44. Middle East & Africa Female Contraception Revenue 2019-2024 ($ millions)
Figure 45. Americas Female Contraception Sales Market Share by Country in 2023
Figure 46. Americas Female Contraception Revenue Market Share by Country (2019-2024)
Figure 47. Americas Female Contraception Sales Market Share by Type (2019-2024)
Figure 48. Americas Female Contraception Sales Market Share by Application (2019-2024)
Figure 49. United States Female Contraception Revenue Growth 2019-2024 ($ millions)
Figure 50. Canada Female Contraception Revenue Growth 2019-2024 ($ millions)
Figure 51. Mexico Female Contraception Revenue Growth 2019-2024 ($ millions)
Figure 52. Brazil Female Contraception Revenue Growth 2019-2024 ($ millions)
Figure 53. APAC Female Contraception Sales Market Share by Region in 2023
Figure 54. APAC Female Contraception Revenue Market Share by Region (2019-2024)
Figure 55. APAC Female Contraception Sales Market Share by Type (2019-2024)
Figure 56. APAC Female Contraception Sales Market Share by Application (2019-2024)
Figure 57. China Female Contraception Revenue Growth 2019-2024 ($ millions)
Figure 58. Japan Female Contraception Revenue Growth 2019-2024 ($ millions)
Figure 59. South Korea Female Contraception Revenue Growth 2019-2024 ($ millions)
Figure 60. Southeast Asia Female Contraception Revenue Growth 2019-2024 ($ millions)
Figure 61. India Female Contraception Revenue Growth 2019-2024 ($ millions)
Figure 62. Australia Female Contraception Revenue Growth 2019-2024 ($ millions)
Figure 63. China Taiwan Female Contraception Revenue Growth 2019-2024 ($ millions)
Figure 64. Europe Female Contraception Sales Market Share by Country in 2023
Figure 65. Europe Female Contraception Revenue Market Share by Country (2019-2024)
Figure 66. Europe Female Contraception Sales Market Share by Type (2019-2024)
Figure 67. Europe Female Contraception Sales Market Share by Application (2019-2024)
Figure 68. Germany Female Contraception Revenue Growth 2019-2024 ($ millions)
Figure 69. France Female Contraception Revenue Growth 2019-2024 ($ millions)
Figure 70. UK Female Contraception Revenue Growth 2019-2024 ($ millions)
Figure 71. Italy Female Contraception Revenue Growth 2019-2024 ($ millions)
Figure 72. Russia Female Contraception Revenue Growth 2019-2024 ($ millions)
Figure 73. Middle East & Africa Female Contraception Sales Market Share by Country (2019-2024)
Figure 74. Middle East & Africa Female Contraception Sales Market Share by Type (2019-2024)
Figure 75. Middle East & Africa Female Contraception Sales Market Share by Application (2019-2024)
Figure 76. Egypt Female Contraception Revenue Growth 2019-2024 ($ millions)
Figure 77. South Africa Female Contraception Revenue Growth 2019-2024 ($ millions)
Figure 78. Israel Female Contraception Revenue Growth 2019-2024 ($ millions)
Figure 79. Turkey Female Contraception Revenue Growth 2019-2024 ($ millions)
Figure 80. GCC Countries Female Contraception Revenue Growth 2019-2024 ($ millions)
Figure 81. Manufacturing Cost Structure Analysis of Female Contraception in 2023
Figure 82. Manufacturing Process Analysis of Female Contraception
Figure 83. Industry Chain Structure of Female Contraception
Figure 84. Channels of Distribution
Figure 85. Global Female Contraception Sales Market Forecast by Region (2025-2030)
Figure 86. Global Female Contraception Revenue Market Share Forecast by Region (2025-2030)
Figure 87. Global Female Contraception Sales Market Share Forecast by Type (2025-2030)
Figure 88. Global Female Contraception Revenue Market Share Forecast by Type (2025-2030)
Figure 89. Global Female Contraception Sales Market Share Forecast by Application (2025-2030)
Figure 90. Global Female Contraception Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Female Contraception
Figure 2. Female Contraception Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Female Contraception Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Female Contraception Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Female Contraception Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Female Contraception Sales Market Share by Country/Region (2023)
Figure 10. Female Contraception Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Birth Control Pills
Figure 12. Product Picture of Contraceptive Injection
Figure 13. Product Picture of Contraceptive Patch
Figure 14. Product Picture of IUDs
Figure 15. Product Picture of Female Condom
Figure 16. Product Picture of Others
Figure 17. Global Female Contraception Sales Market Share by Type in 2023
Figure 18. Global Female Contraception Revenue Market Share by Type (2019-2024)
Figure 19. Female Contraception Consumed in 18-25 Years Old
Figure 20. Global Female Contraception Market: 18-25 Years Old (2019-2024) & (K Units)
Figure 21. Female Contraception Consumed in 26-35 Years Old
Figure 22. Global Female Contraception Market: 26-35 Years Old (2019-2024) & (K Units)
Figure 23. Female Contraception Consumed in 36-45 Years Old
Figure 24. Global Female Contraception Market: 36-45 Years Old (2019-2024) & (K Units)
Figure 25. Female Contraception Consumed in ?45 Years Old
Figure 26. Global Female Contraception Market: ?45 Years Old (2019-2024) & (K Units)
Figure 27. Female Contraception Consumed in Others
Figure 28. Global Female Contraception Market: Others (2019-2024) & (K Units)
Figure 29. Global Female Contraception Sale Market Share by Application (2023)
Figure 30. Global Female Contraception Revenue Market Share by Application in 2023
Figure 31. Female Contraception Sales by Company in 2023 (K Units)
Figure 32. Global Female Contraception Sales Market Share by Company in 2023
Figure 33. Female Contraception Revenue by Company in 2023 ($ millions)
Figure 34. Global Female Contraception Revenue Market Share by Company in 2023
Figure 35. Global Female Contraception Sales Market Share by Geographic Region (2019-2024)
Figure 36. Global Female Contraception Revenue Market Share by Geographic Region in 2023
Figure 37. Americas Female Contraception Sales 2019-2024 (K Units)
Figure 38. Americas Female Contraception Revenue 2019-2024 ($ millions)
Figure 39. APAC Female Contraception Sales 2019-2024 (K Units)
Figure 40. APAC Female Contraception Revenue 2019-2024 ($ millions)
Figure 41. Europe Female Contraception Sales 2019-2024 (K Units)
Figure 42. Europe Female Contraception Revenue 2019-2024 ($ millions)
Figure 43. Middle East & Africa Female Contraception Sales 2019-2024 (K Units)
Figure 44. Middle East & Africa Female Contraception Revenue 2019-2024 ($ millions)
Figure 45. Americas Female Contraception Sales Market Share by Country in 2023
Figure 46. Americas Female Contraception Revenue Market Share by Country (2019-2024)
Figure 47. Americas Female Contraception Sales Market Share by Type (2019-2024)
Figure 48. Americas Female Contraception Sales Market Share by Application (2019-2024)
Figure 49. United States Female Contraception Revenue Growth 2019-2024 ($ millions)
Figure 50. Canada Female Contraception Revenue Growth 2019-2024 ($ millions)
Figure 51. Mexico Female Contraception Revenue Growth 2019-2024 ($ millions)
Figure 52. Brazil Female Contraception Revenue Growth 2019-2024 ($ millions)
Figure 53. APAC Female Contraception Sales Market Share by Region in 2023
Figure 54. APAC Female Contraception Revenue Market Share by Region (2019-2024)
Figure 55. APAC Female Contraception Sales Market Share by Type (2019-2024)
Figure 56. APAC Female Contraception Sales Market Share by Application (2019-2024)
Figure 57. China Female Contraception Revenue Growth 2019-2024 ($ millions)
Figure 58. Japan Female Contraception Revenue Growth 2019-2024 ($ millions)
Figure 59. South Korea Female Contraception Revenue Growth 2019-2024 ($ millions)
Figure 60. Southeast Asia Female Contraception Revenue Growth 2019-2024 ($ millions)
Figure 61. India Female Contraception Revenue Growth 2019-2024 ($ millions)
Figure 62. Australia Female Contraception Revenue Growth 2019-2024 ($ millions)
Figure 63. China Taiwan Female Contraception Revenue Growth 2019-2024 ($ millions)
Figure 64. Europe Female Contraception Sales Market Share by Country in 2023
Figure 65. Europe Female Contraception Revenue Market Share by Country (2019-2024)
Figure 66. Europe Female Contraception Sales Market Share by Type (2019-2024)
Figure 67. Europe Female Contraception Sales Market Share by Application (2019-2024)
Figure 68. Germany Female Contraception Revenue Growth 2019-2024 ($ millions)
Figure 69. France Female Contraception Revenue Growth 2019-2024 ($ millions)
Figure 70. UK Female Contraception Revenue Growth 2019-2024 ($ millions)
Figure 71. Italy Female Contraception Revenue Growth 2019-2024 ($ millions)
Figure 72. Russia Female Contraception Revenue Growth 2019-2024 ($ millions)
Figure 73. Middle East & Africa Female Contraception Sales Market Share by Country (2019-2024)
Figure 74. Middle East & Africa Female Contraception Sales Market Share by Type (2019-2024)
Figure 75. Middle East & Africa Female Contraception Sales Market Share by Application (2019-2024)
Figure 76. Egypt Female Contraception Revenue Growth 2019-2024 ($ millions)
Figure 77. South Africa Female Contraception Revenue Growth 2019-2024 ($ millions)
Figure 78. Israel Female Contraception Revenue Growth 2019-2024 ($ millions)
Figure 79. Turkey Female Contraception Revenue Growth 2019-2024 ($ millions)
Figure 80. GCC Countries Female Contraception Revenue Growth 2019-2024 ($ millions)
Figure 81. Manufacturing Cost Structure Analysis of Female Contraception in 2023
Figure 82. Manufacturing Process Analysis of Female Contraception
Figure 83. Industry Chain Structure of Female Contraception
Figure 84. Channels of Distribution
Figure 85. Global Female Contraception Sales Market Forecast by Region (2025-2030)
Figure 86. Global Female Contraception Revenue Market Share Forecast by Region (2025-2030)
Figure 87. Global Female Contraception Sales Market Share Forecast by Type (2025-2030)
Figure 88. Global Female Contraception Revenue Market Share Forecast by Type (2025-2030)
Figure 89. Global Female Contraception Sales Market Share Forecast by Application (2025-2030)
Figure 90. Global Female Contraception Revenue Market Share Forecast by Application (2025-2030)
